The negative trailing P/E of -9.12 captures the cumulative losses run through 2025 rather than current trading conditions, leaving the 16.25x forward P/E as the more honest read — yet even that sits above Primoris at 13.25x and Great Lakes at 15.74x, peers that consistently convert 3.6% to 8.3% of revenue to net income. The 2.48x price-to-FCF multiple looks optically distressed, but given that ten-quarter FCF has been driven by customer-advance timing rather than operating earnings, the market's skepticism toward the cash flow stream appears well-founded rather than excessive.

The -198.7% print appears to be an artifact of dividing losses by a rapidly contracting equity base — retained earnings fell from $38.3M to $1.9M over the window — rather than a discrete operating event, so the magnitude warrants caution even as the sign is unambiguous. Read alongside a peer group posting ROIC of 9.7% (Great Lakes) to 37.5% (IES), the pattern suggests a business that has not yet demonstrated it earns its cost of capital; the 2026 operating-margin recovery to -0.4% may signal slowing decay, but it does not yet evidence compounding.

With DIO holding near 2-4 days throughout, the CCC is effectively a receivables-versus-payables equation rather than a traditional working-capital management story, so the efficiency gain rests on a single lever. DPO widened only modestly from 33 to 42 days, indicating MTRX has not been stretching suppliers to fund the improvement — the collection cadence is doing the work, which is the higher-quality version of the gain, though DSO at 63 days still leaves roughly two months of revenue outstanding at any given time.

The -27.3x to -71.2x coverage readings through 2025 reflect EBITDA near or below zero rather than a solvency event, and the 2026 recoveries to 12.5x and 22.8x could reverse on modest earnings swings — the 76.05x D/EBITDA print in 2026Q2 against 4.73x in Q3 illustrates how little cushion exists. On the more durable measure, D/E of 0.14 sits well below Primoris (0.76) and Great Lakes (0.89), implying meaningful unused debt capacity, so the practical constraint on the balance sheet appears to be operating performance rather than refinancing or covenant risk.

Because the largest current liability is deferred revenue — an obligation settled by performing work rather than paying cash — the conventional stress test of the sub-1.0 current ratio likely overstates near-term funding risk, and the quick ratio at 0.97 tells essentially the same story given negligible inventory. That said, the sequential decline in deferred revenue from $382.9M in 2026Q2 to $299.9M in 2026Q4 warrants monitoring, since a bookings slowdown would mechanically tighten both liquidity ratios while removing the advance-funded cash inflow that currently supports them.